Revolutionizing Drug Discovery and Delivery
If you had to guess how long it takes for a drug to go from an idea to your pharmacy, what would...
As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is co-founder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company.
My team and I are currently looking to hire an adaptively intelligent technology lead to develop and manage systems that support my Abundance360 community; our year-round Mastermind and Executive program for entrepreneurs, investors, and CEOs. A360 is designed to keep leaders on the cutting edge of exponential tech and help them hone the mindsets critical during this period of rapidly accelerating change.